Genetic Algorithm Sample Clauses

Genetic Algorithm. The second script contains two variants of a genetic algorithm [Deb12] that have two parameters to tune their behaviour. The variations offer choices of both how the initial population is generated and how parents are selected to produce each subsequent generation. The parameters affect the size of the initial population and how long the algorithm will continue if no better results are being found. The following subsections outline the steps take by the genetic algorithm. in D3.2a [FGPP16] that aims to provide guidance on what this size should be. It is on the generation of this initial set that the two genetic algorithms differ. One version of the script produces an entirely random set of designs and then proceeds to the next step, while the other version attempts to produce a set of designs that is evenly distributed across the design space. Again the experimentation in D3.2a aims to provide guidance about which of these options should be used and when. Evaluation and ranking The second step in the genetic algorithm is to evaluate the new designs according to the objectives in the DSE config file (section 4.2.2) and then to place them in a partial order according to the ranking defined (section 4.2.4).
Genetic Algorithm. The genetic algorithm that is used in this article is based on algorithms used in ▇▇▇▇▇▇▇▇ et al. [29, 30] and ▇▇▇▇▇▇▇▇▇▇ et al. [11, 7]. The genetic algorithm for all experiments is a (10, 100) strategy where 100 stands for the number of individuals in the pool and 10 for the number of parents that is selected from that pool. Parents are selected by choosing the ten fittest individuals from the population. Every parent is then copied ten times every generation (making 100 children) and all individuals are mutated using a mutation operator. Unlike previous experiments, no crossover was used in these experiments. Not only have earlier results by ▇▇▇▇▇▇▇▇▇▇ et al. [11, 7] (see Chapter 4) shown that the impact of crossover on the Majority Problem is minimal, but investigating the effect of self-adaptation is also a lot easier without taking into account crossover. The algorithm uses a comma strategy. This is also different from previous experiments, which used a plus strategy. Preliminary experiments seem to suggest that self-adaptation of mutation rates in GA do not work very well in a plus strategy. This probably has to do with the success rate in the al- gorithm and the fact that the mutation rate only changes if the individual is mutated. In a plus (or elitist) strategy the parents are not mutated and copied to the next generation without any changes. If the success rate in the algorithm goes down, these elite individuals will drown out any form of diversity while at the same time keeping the mutation rate identical and probably too high. Using a plus strategy with self adaptation is probably possible if this effect can be countered somehow and this is worth investigat- ing in the future, but by choosing a comma strategy this problem is evaded. Every surviving individual is mutated every generation, which results in a dynamic mutation rate that evolves at the same time as the individuals object values, thus forcing the algorithm to select the best mutation rate at different stages in the optimization.
Genetic Algorithm. The second script contains two variants of a genetic algorithm [Deb12] that have two parameters to tune their behaviour. The variations o er choices of both how the initial population is generated and how parents are selected to produce each subsequent generation. The parameters a ect the size of the initial population and how long the algorithm will continue if no better results are being found. The strength of a closed loop search, such is this genetic search, is that they will perform a search of the design space with- out testing each design and so require less CPU time than an exhaustive search [FGPL17]. This strength comes at the cost of guaranteeing of nding globally optimal designs, the search may instead nd some set of local opti- mums and return those. The following subsections outline the steps take by the genetic algorithm. Initial population generation The rst step in the genetic algorithm is to generate an initial population of designs. The size of this initial set is a parameter the user may set and there is ongoing work that is described in D3.2a [FGPP16] that aims to provide guidance on what this size should be. It is on the generation of this initial set that the two genetic algorithms di er. One version of the script produces an entirely random set of designs and then proceeds to the next step, while the other version attempts to produce a set of designs that is evenly distributed across the design space. Again the experimentation in D3.2a aims to provide guidance about which of these options should be used and when.

Related to Genetic Algorithm

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

  • Study Population ‌ Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).

  • Application of Funding Techniques to Programs 6.3.1 The State shall apply the following funding techniques when requesting Federal funds for the component cash flows of the programs listed in sections 4.2 and 4.3 of this Agreement. 6.3.2 Programs Below are programs listed in Section 4.2 and Section 4.3.

  • Screening The Health Plan must work with contracted providers to conduct interperiodic EPSDT screens on RIte Care and all ACA Adult Expansion Population members under age 21 (i.e. 19 and 20-year old under this Agreement) to identify health and developmental problems in conformance with ATTACHMENT ED to this Agreement. Additional screens should be provided as Medically Necessary. At a minimum, these screens must include: • A comprehensive health and developmental history, including health education, nutrition assessment, immunization history, and developmental assessment • Immunizations according to the Rhode Island EPSDT Periodicity Schedule • An unclothed physical examination • Laboratory tests including lead, TB, and newborn screenings as medically indicated • Vision testing • Hearing testing • Dental screening oral examination by PCP as part of a comprehensive examination required before age one (1) • All other medically indicated screening services • And provide EOHHS with a list of established CPT/HCPC codes used to identify all billable services included in the EPSDT schedule.